Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Neoplasm Metastasis in Poland
Total 0 results
Nothing found
Sponsors and Collaborators
Eurofins Genoma
iCAD
Mª Victoria Maestre Sanchez
GFI
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Alma Lasers Inc.
Hospital ASEPEYO Sant Cugat
Kupfer, David J., M.D.
Apollo Neuroscience, Inc.
Neurophth Therapeutics Inc
Everett Meyer
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hospital Durand, Argentina
Agency for Science, Technology and Research
RMIT University, Melbourne, Australia
Korean Society of Spine Surgery
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Aptis Medical
ASST Cremona, Cremona
Nacuity Pharmaceuticals, Inc.
View Full List
Medical Conditions
Immune-Mediated Inflammatory Disease
Gastric Cancer Stage IIIB-IIIC
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Treatment Decisions
Major Liver Surgery
RISS Stage III Plasma Cell Myeloma
Corneal Cross-Linking
T-LGL Leukemia
Disorder of Fluid Balance
Fever
Splenic Trauma
Metachronous Adenoma
Rheumatoid Arthritis(RA)
Dienogest
Chronic Constipation Symptoms
Luteal Phase Support
Scleredema
The Strength Properties of the Aorta in Vitro
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Recurrent Clear Cell Sarcoma of Soft Tissue
View Full List
Drug Interventions
Camptosar
Anticholinergic
MLN2480
GLPG1837 multiple ascending doses
TPN-101
OnabotulinumtoxinA
Oxycodone/acetaminophen 5/325 mg
Olopatadine
PD-1/PD-L1 inhibitor
Intravenous Formulation of PD-0332991
Midazolam
Desvenlafaxine
Intravenous deferiprone
RDX227675
Fospropofol disodium, propofol
Standard of care (SOC) for COVID-19
THC
Capecitabine/cisplatin
Capecitabine and IMRT (if randomized to this arm)
Letrozole
View Full List
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Bangladesh
Contract Research Organizations in Guatemala
Contract Research Organizations in India
Contract Research Organizations in Liberia
Contract Research Organizations in Malawi
Contract Research Organizations in Malta
Contract Research Organizations in Nigeria
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in South Korea
Contract Research Organizations in Taiwan
Contract Research Organizations in Thailand
Contract Research Organizations in United Arab Emirates
CRO list by country
CROs in Japan
Bioclinica
Caidya
GenScript
Clinlogix
Lonza
MakroCare
PRA Health Sciences
A2 Healthcare Corporation
PPD
Asklep
All CROs in Japan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe